According to Cosmo Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.08. At the end of 2022 the company had a P/S ratio of 10.1.
Year | P/S ratio | Change |
---|---|---|
2022 | 10.1 | -38.42% |
2021 | 16.4 | -12.45% |
2020 | 18.7 | 14.12% |
2019 | 16.4 | -6.98% |
2018 | 17.6 | -36.7% |
2017 | 27.9 | -15.47% |
2016 | 33.0 | -5.57% |
2015 | 34.9 | 61.49% |
2014 | 21.6 | 18.54% |
2013 | 18.2 | 202.16% |
2012 | 6.04 | |
2009 | 5.97 | 41.08% |
2008 | 4.23 | -47.98% |
2007 | 8.13 |